Half-year report · Q2
4572.TEDINET S100WEUS
Period2025-01-01 → 2025-06-30
Filed2025-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥636m | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥316m | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥2.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥3.7bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥244m | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥297m | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥222m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥567m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥279m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-121.64 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.25 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.1bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥24m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 418
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 504500 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0264 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 500461 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0261 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 500000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0261 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 418800 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0219 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 350000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0183 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 333900 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0174 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 255000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0133 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 183966 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0096 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 171711 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0089 | |
| Number of shares held | CurrentQuarterInstant | 4027550 | |
| Shareholding ratio | CurrentQuarterInstant | 0.2108 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 11100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 190960 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 19096000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 8400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 19115500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 190960 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 11100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 11100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0005 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 11100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 11100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0005 | |
| Cash and deposits | Prior1YearInstant | 2108484000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 1060569000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 87088000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 71940000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 108064000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 113272000 | JPY |
| Work in process | Prior1YearInstant | 9069000 | JPY |
| Work in process | CurrentQuarterInstant | 13989000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 37016000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 36335000 | JPY |
| Advance payments trade | Prior1YearInstant | 231819000 | JPY |
| Advance payments trade | CurrentQuarterInstant | 194427000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |